Endometriosis Blood Test: An End to Years of Agony? - Report - MDSpire

Endometriosis Blood Test: An End to Years of Agony?

  • April 9, 2026

  • 3 min

Share

Clinical Report: Endometriosis Blood Test: An End to Years of Agony?

Overview

A novel multi-marker blood test shows promise in accurately diagnosing endometriosis, potentially identifying cases missed by standard imaging techniques. This advancement could significantly reduce the time to diagnosis for symptomatic women, addressing a critical gap in current clinical practice.

Background

Endometriosis affects an estimated 5 to 10 percent of women of reproductive age and is often associated with infertility and chronic pelvic pain. Diagnosis is frequently delayed due to symptom overlap with other conditions and reliance on invasive procedures like laparoscopy. The introduction of a blood-based diagnostic test could revolutionize the approach to identifying this condition, enabling earlier intervention and improved patient outcomes.

Data Highlights

BiomarkersMethodDiagnostic Accuracy
3 microRNAsqPCRAUC 0.944
3 proteinsAutomated immunoassay80% sensitivity
1 steroid hormoneMachine learning model97.5% specificity

Key Findings

  • The blood test integrates seven biomarkers, improving diagnostic accuracy for endometriosis.
  • It identified cases missed by ultrasound or MRI, reducing false negatives in clinical pathways.
  • The test maintains consistent performance across different menstrual cycle phases.
  • Utilizes established laboratory platforms, making it compatible with existing clinical infrastructure.
  • Supports the concept of endometriosis as a systemic condition with detectable circulating molecular signatures.

Clinical Implications

The introduction of this blood test could facilitate earlier diagnosis and treatment of endometriosis, potentially improving patient quality of life. Clinicians may consider incorporating this assay into their diagnostic workflows to enhance accuracy and reduce reliance on invasive procedures.

Conclusion

This multi-marker blood test represents a significant advancement in the diagnostic landscape for endometriosis, promising to streamline the diagnostic process and improve outcomes for affected women.

References

  1. Correspondence: Recurring Gastrointestinal Symptoms Associated with Isolated Endometriosis in a Middle-Aged Woman, Surgical Endoscopy, 2016 -- https://link.springer.com/article/10.1007/s00384-016-2522-9
  2. Endometriosis explained: A guide to managing pain and fertility, Mayo Clinic, 2023 -- https://medprofvideos.mayoclinic.org/videos/endometriosis-explained-a-guide-to-managing-pain-and-fertility
  3. Comprehensive Surgical Approaches for Managing Severe Posterior Compartment Endometriosis, Surgical Endoscopy, 2024 -- https://link.springer.com/article/10.1007/s00464-024-10969-7
  4. Consensus Guidelines from ESUR on MRI Protocols for Endometriosis: Terminology and Compartmental Analysis, European Radiology, 2025 -- https://link.springer.com/article/10.1007/s00330-025-11611-3
  5. ACOG Publishes New Endometriosis Clinical Guidance, Aiming to Shorten Time to Diagnosis and Improve Access to Care, ACOG, 2026 -- https://www.acog.org/news/news-releases/2026/02/acog-publishes-new-endometriosis-clinical-guidance-aiming-shorten-time-diagnosis-improve-access-care?utm_source=openai
  6. ESHRE guideline: endometriosis, PMC, 2022 -- https://pmc.ncbi.nlm.nih.gov/articles/PMC8951218/?utm_source=openai
  7. Diagnostic value of MiRNAs in endometriosis: a systematic review and meta-analysis, BMC Women's Health, 2026 -- https://link.springer.com/article/10.1186/s12905-026-04281-w?utm_source=openai
  8. ACOG Publishes New Endometriosis Clinical Guidance, Aiming to Shorten Time to Diagnosis and Improve Access to Care | ACOG
  9. ESHRE guideline: endometriosis - PMC
  10. Diagnostic value of MiRNAs in endometriosis: a systematic review and meta-analysis | BMC Women's Health | Springer Nature Link

Original Source(s)

Related Content